Found 12 matching trials
Study of the Fed-Fast Pharmocokinetics and Bioequivalance of 300mg Capsules of Droxidopa
PHASE1One purpose of this study is to determine if taking droxidopa after eating ...
NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease
PHASE1This clinical trial will evaluate the safety, tolerability, dosing, and eff...
Location
Vagelos College of Physicians and Surgeons, Columbia University
A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
PHASE3This is a study to evaluate the effects of an investigational drug, Droxido...
Location
Neurology Neurodiagnostic Lab
Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension
PHASE4To evaluate the time to treatment intervention in patients with Parkinson's...
Location
MDFirst Research - Chandler
Long Term Treatment With L-DOPS
N/AThis study is designed to supply L-DOPS (droxidopa) on a long term basis to...
Status
Approved For Marketing
Location
Vanderbilt University Medical Center
NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome
PHASE1The purpose of this study is to evaluate whether Northera (Droxidopa) is sa...
Location
Vagelos College of Physicians and Surgeons, Columbia University
Droxidopa to Increase Mean Arterial Pressure in Decompensated Cirrhosis Patients With Acute Kidney Injury
PHASE2This study tests whether a medication called droxidopa can help improve blo...
Location
Columbia University Irving Medical Center
Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson Disease
PHASE2This research study is being done to determine whether treatment with L- Di...
Location
Barrow Neurological Institute/St. Joseph's Hospital and Medical Center
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
PHASE3Evaluate the clinical efficacy and safety of droxidopa versus placebo over ...
Location
NYU Langone Medical Center
A Multi-Center, Open-Label Study
PHASE1This study will be an open-label, single-treatment, single-dose, parallel g...